Baricitinib for refractory Takayasu arteritis: a prospective cohort study in a tertiary referral centre
Objective To investigate the treatment efficacy and safety of baricitinib in patients with refractory Takayasu arteritis (TAK).Methods We performed a prospective cohort study in which baricitinib 4 mg daily was prescribed to patients with refractory TAK, combined with oral glucocorticoids (GCs).Resu...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2024-02-01
|
| Series: | RMD Open |
| Online Access: | https://rmdopen.bmj.com/content/10/1/e003985.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|